Clinical Trial Update: Safety/Feasibility Study of HBOC-201 in Amputation at/Below Knee From Critical Lower Limb Ischemia [Phase 2]

View source ↗

Summary

Phase 2 safety/feasibility trial of HBOC-201 in below-knee amputation due to critical limb ischemia has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Limb Ischemia
• Peripheral Artery Disease

Drugs mentioned

• HBOC-201

Snippet

Sponsor: Biopure Corporation | Conditions: Peripheral Vascular Disease | Phase 2 | Status: TERMINATED